Vir Biotechnology Names Jason O’Byrne CFO
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
- Latest
- Trending
Vir Biotechnology appoints Jason O’Byrne as CFO, effective October 2, 2024, boosting financial strategy and leadership.
Macro expert Lyn Alden sees Bitcoin rising amid US debt, citing high deficits and global liquidity trends in the long ...
Sevens Report warns S&P 500 could fall to low 4,000s if economic conditions worsen, tech stocks disappoint.
HPE shares fall 6.4% amid $1.35B convertible stock offer to fund Juniper acquisition in $14B cash deal.
Samsung SDI to sell its polarizing film business to Wuxi Hengxin Optoelectronic for $836 million, shifting focus to semiconductors.
EU to lower tariffs on Tesla EVs to 7.8% from 9%, while other Chinese EV makers see slight adjustments in ...
Apple unveils iPhone 16 with AI chips, revolutionizing mobile tech.
NBT Bancorp's acquisition of Evans Bancorp expands its reach in New York, aims to boost market share and diversify assets.
NetSuite introduces AI to streamline finance tasks, enhance reporting, and support strategic growth opportunities.
Bitcoin and Ether continue their decline amid market volatility. Experts analyze the impact on institutional investments.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.